Avalon Investment & Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $24.7M | Buy |
102,009
+6,783
| +7% | +$1.67M | 0.68% | 43 |
|
|
2022
Q4 | $25M | Sell |
95,226
-776
| -0.8% | -$208K | 0.71% | 40 |
|
|
2022
Q3 | $21.6M | Sell |
96,002
-35,309
| -27% | -$8.56M | 0.67% | 46 |
|
|
2022
Q2 | $31.9M | Sell |
131,311
-20,619
| -14% | -$5.05M | 0.9% | 42 |
|
|
2022
Q1 | $36.7M | Buy |
151,930
+4,259
| +3% | +$979K | 0.89% | 42 |
|
|
2021
Q4 | $33.2M | Buy |
147,671
+20,034
| +16% | +$4.23M | 0.82% | 44 |
|
|
2021
Q3 | $27.1M | Sell |
127,637
-13,184
| -9% | -$3.03M | 0.63% | 53 |
|
|
2021
Q2 | $34.3M | Sell |
140,821
-13,978
| -9% | -$3.44M | 0.76% | 41 |
|
|
2021
Q1 | $38.5M | Sell |
154,799
-54,481
| -26% | -$13M | 0.88% | 37 |
|
|
2020
Q4 | $48.1M | Sell |
209,280
-48,552
| -19% | -$11.2M | 0.98% | 23 |
|
|
2020
Q3 | $65.5M | Buy |
257,832
+30,114
| +13% | +$7.46M | 1.46% | 13 |
|
|
2020
Q2 | $53.7M | Sell |
227,718
-591
| -0.3% | -$135K | 1.24% | 19 |
|
|
2020
Q1 | $46.3M | Buy |
228,309
+10,735
| +5% | +$2.34M | 1.18% | 20 |
|
|
2019
Q4 | $52.5M | Sell |
217,574
-835
| -0.4% | -$184K | 1.07% | 22 |
|
|
2019
Q3 | $42.3M | Buy |
218,409
+5,336
| +3% | +$1.02M | 0.93% | 23 |
|
|
2019
Q2 | $39.3M | Buy |
213,073
+23,634
| +12% | +$4.23M | 0.87% | 28 |
|
|
2019
Q1 | $36M | Sell |
189,439
-26,857
| -12% | -$5.13M | 0.82% | 27 |
|
|
2018
Q4 | $42.1M | Buy |
216,296
+85,103
| +65% | +$16.6M | 1.09% | 19 |
|
|
2018
Q3 | $27.2M | Buy |
131,193
+5,002
| +4% | +$986K | 0.76% | 35 |
|
|
2018
Q2 | $23.3M | Sell |
126,191
-4,824
| -4% | -$853K | 0.69% | 47 |
|
|
2018
Q1 | $22.3M | Sell |
131,015
-933
| -0.7% | -$171K | 0.69% | 48 |
|
|
2017
Q4 | $22.9M | Sell |
131,948
-8,652
| -6% | -$1.53M | 0.72% | 40 |
|
|
2017
Q3 | $26.2M | Sell |
140,600
-328
| -0.2% | -$58.1K | 0.83% | 31 |
|
|
2017
Q2 | $24.3M | Sell |
140,928
-1,729
| -1% | -$281K | 0.81% | 35 |
|
|
2017
Q1 | $23.4M | Sell |
142,657
-10,495
| -7% | -$1.74M | 0.8% | 35 |
|
|
2016
Q4 | $22.4M | Buy |
153,152
+8,760
| +6% | +$1.32M | 0.81% | 36 |
|
|
2016
Q3 | $24.1M | Sell |
144,392
-33,845
| -19% | -$5.72M | 0.91% | 40 |
|
|
2016
Q2 | $27.1M | Sell |
178,237
-6,580
| -4% | -$1.02M | 1.05% | 32 |
|
|
2016
Q1 | $27.7M | Buy |
184,817
+69,224
| +60% | +$10.3M | 1.2% | 25 |
|
|
2015
Q4 | $18.8M | Sell |
115,593
-9,721
| -8% | -$1.53M | 0.81% | 42 |
|
|
2015
Q3 | $17.3M | Buy |
125,314
+4,432
| +4% | +$699K | 0.77% | 47 |
|
|
2015
Q2 | $18.6M | Buy |
120,882
+2,245
| +2% | +$360K | 0.8% | 43 |
|
|
2015
Q1 | $19M | Buy |
118,637
+7,595
| +7% | +$1.2M | 0.83% | 46 |
|
|
2014
Q4 | $17.7M | Buy |
111,042
+9,933
| +10% | +$1.55M | 0.81% | 42 |
|
|
2014
Q3 | $14.2M | Buy |
101,109
+2,148
| +2% | +$280K | 0.72% | 44 |
|
|
2014
Q2 | $11.7M | Buy |
98,961
+3,006
| +3% | +$348K | 0.59% | 62 |
|
|
2014
Q1 | $11.8M | Buy |
95,955
+18,458
| +24% | +$2.24M | 0.65% | 57 |
|
|
2013
Q4 | $8.84M | Buy |
77,497
+1,100
| +1% | +$125K | 0.49% | 89 |
|
|
2013
Q3 | $8.55M | Sell |
76,397
-7,397
| -9% | -$802K | 0.55% | 75 |
|
|
2013
Q2 | $8.27M | Buy |
+83,794
| New | +$8.7M | 0.49% | 82 |
|
Other funds holding AMGN
Avalon Investment & Advisory's AMGN Position: Q1 2023 in Review
Avalon Investment & Advisory increased its Amgen (AMGN) stake by 7.1% in Q1 2023, buying an estimated $1.67M and bringing the position to 102,009 shares worth $24.7M. The position accounts for 0.68% of the portfolio, ranked #43.
Avalon Investment & Advisory first reported a position in AMGN in Q2 2013 and has held it in 40 quarters since. The position peaked at $65.5M in Q3 2020. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.
- Avalon Investment & Advisory held 102,009 shares of Amgen worth $24.7M as of Q1 2023.
- Avalon Investment & Advisory bought 6,783 Amgen shares in Q1 2023, an estimated $1.67M.
- Amgen made up 0.68% of Avalon Investment & Advisory's portfolio in Q1 2023, its #43 holding.
- Avalon Investment & Advisory first reported a position in Amgen in Q2 2013 and has held it in 40 quarters since.
- Avalon Investment & Advisory's Amgen position peaked at $65.5M in Q3 2020.
- 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.
Based on Avalon Investment & Advisory's 13F filing for Q1 2023, filed 15 May 2023.